Abstract
Oxaliplatin-induced immune thrombocytopenia is a rare manifestation of oxaliplatin hypersensitivity, presenting as an acute onset of severe thrombocytopenia after oxaliplatin administration. No standard therapeutic approach outside of permanent discontinuation of oxaliplatin exists. Here, we present a case of oxaliplatin-induced immune thrombocytopenia occurring after oxaliplatin retreatment for metastatic colon cancer. Possible mechanisms of disease and approach to treatment are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | e1-e4 |
| Journal | Clinical Colorectal Cancer |
| Volume | 20 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antineoplastic Combined Chemotherapy Protocols/adverse effects
- Chemotherapy, Adjuvant/adverse effects
- Colectomy
- Colorectal Neoplasms/blood
- Female
- Fluorouracil/adverse effects
- Humans
- Leucovorin/adverse effects
- Middle Aged
- Organoplatinum Compounds/adverse effects
- Oxaliplatin/adverse effects
- Thrombocytopenia/blood
Fingerprint
Dive into the research topics of 'Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver